Literature DB >> 23365593

Treatment strategy: Role of enfuvirtide in managing treatment-limiting side effects.

Christos Tsoukas1.   

Abstract

Side effects can limit the options available to physicians for the treatment of HIV infection. Management of these side effects is essential, to avoid cessation of treatment. The entry inhibitor enfuvirtide can be useful as one of three active agents in an HIV treatment regimen as a way to both reduce treatment-limiting side effects and provide an efficacious agent for viral control. In the present case, the patient had a problematic and lengthy treatment history, with numerous concomitant conditions. His latest regimen, which includes an agent in a new drug class (enfuvirtide), has maintained HIV suppression while minimizing toxicity.

Entities:  

Keywords:  Antiretroviral agents; HIV fusion inhibitors; HIV infection

Year:  2007        PMID: 23365593      PMCID: PMC3555490     

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  1 in total

1.  Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks.

Authors:  Benoit Trottier; Sharon Walmsley; Jacques Reynes; Peter Piliero; Mary O'Hearn; Mark Nelson; Julio Montaner; Adriano Lazzarin; Jacob Lalezari; Christine Katlama; Keith Henry; David Cooper; Bonaventura Clotet; Keikawus Arastéh; Jean-François Delfraissy; Hans-Jürgen Stellbrink; Joep Lange; Daniel Kuritzkes; Joseph J Eron; Calvin Cohen; Tosca Kinchelow; Anne Bertasso; Emily Labriola-Tompkins; Anna Shikhman; Belinda Atkins; Laurence Bourdeau; Christopher Natale; Fiona Hughes; Jain Chung; Denise Guimaraes; Claude Drobnes; Silvia Bader-Weder; Ralph Demasi; Lynn Smiley; Miklos P Salgo
Journal:  J Acquir Immune Defic Syndr       Date:  2005-12-01       Impact factor: 3.731

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.